These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pulmonary Arterial Hypertension: Too Complex for Physicians, Too Complex for ICD Diagnosis Codes. Callahan SJ; Papani R Chest; 2019 May; 155(5):1077. PubMed ID: 31060691 [No Abstract] [Full Text] [Related]
25. Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension. Richter MJ; Tello K Am J Respir Crit Care Med; 2020 Feb; 201(4):403-405. PubMed ID: 31726011 [No Abstract] [Full Text] [Related]
26. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition. Pullamsetti SS; de Jesus Perez VA Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389 [No Abstract] [Full Text] [Related]
27. BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension? Chen L; Liu C; Lu W; Wang T Am J Respir Crit Care Med; 2020 May; 201(10):1313. PubMed ID: 32032498 [No Abstract] [Full Text] [Related]
28. Does Golden Ratio Reside in Pulmonary Circulation? Yetkin E; Çuğlan B; Turhan H; Ozturk S Chest; 2019 Sep; 156(3):629-630. PubMed ID: 31511152 [No Abstract] [Full Text] [Related]
29. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension. Grinnan D; Farkas L Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752 [No Abstract] [Full Text] [Related]
30. Risk of Pulmonary Arterial Hypertension During Qing-Dai Use for the Treatment of Ulcerative Colitis. Adachi S; Nakano Y; Kondo T Circ J; 2020 Jul; 84(8):1235-1236. PubMed ID: 32655110 [No Abstract] [Full Text] [Related]
32. Questions Regarding the Value of CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al. Zhou RP; Wei X; Ma GG; Zhu F; Chen FH; Hu W Arthritis Rheumatol; 2019 Apr; 71(4):653-654. PubMed ID: 30281217 [No Abstract] [Full Text] [Related]
33. Reply to Chen Provencher S; Boucherat O; Berger RMF; Goumans MJ; Bonnet S Am J Respir Crit Care Med; 2020 May; 201(10):1313-1314. PubMed ID: 32032495 [No Abstract] [Full Text] [Related]
34. IL-6 in pulmonary hypertension: why novel is not always best. Toshner M; Rothman A Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32300021 [No Abstract] [Full Text] [Related]
35. Insufficient Evidence to Consider CCL21 a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al. Xu WD; Su LC; Huang AF Arthritis Rheumatol; 2019 Apr; 71(4):654-655. PubMed ID: 30653848 [No Abstract] [Full Text] [Related]